Immune checkpoint functional assay for T cell activation evaluates how therapeutic candidates modulate immune responses. By stimulating T cells and measuring proliferation, cytokine release, and cytotoxicity, researchers can assess the efficacy of inhibitors targeting proteins like PD-1 or CTLA-4. These assays help identify compounds that restore immune function, supporting cancer immunotherapy development and mechanistic studies.
